IP Library Granted Patent US 7,998,700
Granted Patent B2
US 7,998,700 · App. 11/092,509 · Granted Aug 16, 2011

Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellulary in a staining or sorting process

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,998,700
App. No.
11/092,509
Granted
Aug 16, 2011
Kind
B2
Abstract

Staining mixtures comprising viable spermatozoa, a composition which regulates oxidation/reduction reactions intracellularly or extracellularly, and a DNA selective dye are disclosed. The cells contained in such suspensions tend to have a greater capacity for enduring the various process steps typically associated with the sorting of sperm cells into gender enriched populations, thereby resulting in post-sort compositions with an increased number of viable or motile sperm. Processes for staining sperm cells comprising the formation of a staining mixture are also disclosed.

Claims (22)

1. A staining mixture comprising viable spermatozoa, a buffer solution, pyruvate, and a DNA selective dye, the concentration of the pyruvate being about 15 mM to about 50 mM.

2. The staining mixture of claim 1 , wherein the mixture further comprises a composition selected from the group consisting of vitamin K, lipoic acid, glutathione, flavins, quinones, superoxide dismutase, superoxide dismutase mimics, and any combinations thereof.

3. The staining mixture of claim 2 , wherein the mixture further comprises a composition selected from the group consisting of vitamin K, lipoic acid, and combinations thereof.

4. The staining mixture of claim 1 , wherein the composition comprises pyruvate at a concentration selected from a group consisting of about 15 mM, about 25 mM, and about 50 mM.

5. The staining mixture of claim 2 , wherein the composition comprises vitamin K at a concentration selected from the group consisting of about 10 μM, about 50 μM, about 75 μM, and about 100 μM.

6. The staining mixture of claim 2 , wherein the composition comprises lipoic acid at a concentration selected from the group consisting of about 0.1 mM, about 0.5 mM, about 0.75 mM, about 1.0 mM, and about 1.5 mM.

7. The staining mixture of claim 1 , wherein the DNA selective dye is a DNA selective fluorescent dye.

8. The staining mixture of claim 2 , wherein the DNA selective dye is a DNA selective fluorescent dye.

9. The staining mixture of claim 1 , wherein the dye is a UV excitable or a visible light excitable dye.

10. The staining mixture of claim 2 , wherein the dye is a UV excitable or a visible light excitable dye.

11. The staining mixture claim 1 , wherein the dye is selected from the group consisting of Hoechst 33342, Hoechst 33258, SYBR-14, and bisbenzimide-BOD1PY® conjugate 6-{[3-((2Z)-2-{[1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl]methylene}-2H-pyrrol-5-yl)propanoyl]amino}-N-[3-(methyl{3-[({4-[6-(4-methylpiperazin-1-yl)-1H,3′H-2,5′-bibenzimidazol-2′-yl]phenoxy}acetyl)amino]propyl}amino)propyl]hexanamide.

12. The staining mixture claim 2 , wherein the dye is selected from the group consisting of Hoechst 33342, Hoechst 33258, SYBR-14, and bisbenzimide-BOD1PY® conjugate 6-{[3-((2Z)-2-{[1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl]methylene}-2H-pyrrol-5-yl)propanoyl]amino}-N-[3-(methyl{3-[({4-[6-(4-methylpiperazin-1-yl)-1H,3′H-2,5′-bibenzimidazol-2′-yl]phenoxy}acetyl)amino]propyl}amino)propyl]hexanamide.

13. The staining mixture of claim 1 , wherein the staining mixture further comprises a buffer that inhibits sperm motility.

14. The staining mixture of claim 2 , wherein the staining mixture further comprises a buffer that inhibits sperm motility.

15. The staining mixture of claim 13 , wherein the buffer is a carbonate-based buffer.

16. The staining mixture of claim 14 , wherein the buffer is a carbonate-based buffer.

17. The staining mixture of claim 13 , wherein the buffer comprises 0.097 moles/L of NaHCO 3 , 0.173 moles/L of KHCO 3 , 0.090 moles/L C 6 H 8 O 7 .H 2 O in water.

18. The staining mixture of claim 1 , wherein the composition comprises pyruvate at a concentration of about 15 mM to about 40 mM.

19. The staining mixture of claim 1 , wherein the composition comprises pyruvate at a concentration of above about 15 mM to about 20 mM.

20. The staining mixture of claim 1 , wherein the composition comprises pyruvate at a concentration of 25 mM to about 50 mM.

21. The staining mixture of claim 1 , wherein the buffer is selected from a group consisting of: a TRIS and citric acid monohydrate buffer, a TRIS and TES buffer, a Sodium Citrate buffer, and a HEPEs buffer.

22. A staining mixture comprising viable bovine spermatozoa, pyruvate, and a DNA selective dye, the concentration of the pyruvate being about 15 mM to about 50 mM.

Assignments (6)
SECURITY INTEREST Recorded Mar 31, 2021
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0492 →
RELEASE OF SECURITY INTEREST Recorded Mar 19, 2021
From: BBVA USA, FORMERLY KNOWN AS COMPASS BANK
To: INGURAN, LLC
Reel/Frame 055646/0042 →
SECURITY AGREEMENT Recorded Sep 10, 2012
From: INGURAN, LLC
To: COMPASS BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 028924/0254 →
SECURITY AGREEMENT Recorded Nov 20, 2009
From: INGURAN, LLC
To: COMPASS BANK
Reel/Frame 023549/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2008
From: MONSANTO TECHNOLOGY LLC
To: INGURAN, LLC
Reel/Frame 020467/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2005
From: LUDWIG, CINDY L.; GRAHAM, JEFFREY A.; CROWLEY, KATHLEEN S.; ANZAR, MUHAMMAD
To: MONSANTO TECHNOLOGY LLC
Reel/Frame 016488/0920 →